Quantum Cyber N.V. (QUCY)
Data as of , from SEC Form 4 filings.
See up to 3 months of QUCY. The 7-day demo opens the 1M and 3M ranges and puts QUCY on your watchlist.
Start 7-day demoLatest QUCY insider trades
About Quantum Cyber N.V. (QUCY)
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
- MAINZ
- 13
- 2021
- XNAS
QUCY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 2,365,759 | |
| Other acquisition / disposition | 8 | 58,182,200 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
QUCY insider transactions (Form 4)
3222 Form 4 filings on record, the earliest from Jan 16, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Stock Option (Right to Buy) | 212,500 | $0.00 | - | ||
| David E. Lazar - Officer | Other | Ordinary Shares | 9,000,000 | $9.00 | $81.00M | |
| David E. Lazar - Officer | Other | Ordinary Shares | 9,000,000 | $9.00 | $81.00M | |
| David E. Lazar - Officer | Other | Ordinary Shares | 9,000,000 | $9.00 | $81.00M | |
| David E. Lazar - Officer | Other | Ordinary Shares | 28,057,500 | $225.00 | - | |
| David E. Lazar - Officer | Other | Series A Preferred Shares | 1,000,000 | $0.00 footnote F1 | - | |
| David E. Lazar - Officer | Other | Series B Preferred Shares | 1,000,000 | $0.00 footnote F1 | - | |
| David E. Lazar - Officer | Other | Series C Preferred Shares | 1,000,000 | $0.00 footnote F1 | - | |
| David E. Lazar - Officer | Other | Series D Preferred Shares | 124,700 | $0.00 footnote F1 | - | |
| ||||||
| Peter O'Rourke - Director | Grant or award | Stock Option (Right to Buy) | 191,860 footnote F1 | $0.00 | - | |
| ||||||
| David Natan - Director | Grant or award | Stock Option (Right to Buy) | 191,860 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Stock Option (Right to Buy) | 212,500 | $0.00 | - | ||
| Louis R. Buffalino - Director | Grant or award | Stock Option (Right to Buy) | 425,000 | $0.00 | - | |
| Avraham Ben-Tzvi - Director | Grant or award | Ordinary Shares | 112,859 footnote F1 | $0.00 | - | |
| ||||||
| Peter O'Rourke - Director | Grant or award | Stock Option (Right to Buy) | 190,840 | $0.00 | - | |
| David Natan - Director | Grant or award | Stock Option (Right to Buy) | 190,840 | $0.00 | - | |
| Grant or award | Stock Option (Right to Buy) | 212,500 | $0.00 | - | ||
| Louis R. Buffalino - Director | Grant or award | Stock Option (Right to Buy) | 425,000 | $0.00 | - | |
| Peter O'Rourke - Director | Grant or award | Stock Option (Right to Buy) | 112,859 | $0.00 | - | |
| Avraham Ben-Tzvi - Director | Grant or award | Ordinary Shares | 137,141 | $0.00 | - | |
| David Natan - Director | Grant or award | Ordinary Shares | 137,141 | $0.00 | - | |
| David E. Lazar - Officer | Grant or award | Series D Preferred Shares | 1,000,000 | $1.50 footnote F2 | $1.50M | |
| David E. Lazar - Officer | Grant or award | Series E Preferred Shares | 1,000,000 | $1.50 footnote F2 | $1.50M | |
| ||||||
| David E. Lazar - Director | Grant or award | Series A Preferred Shares | 1,000,000 | - footnote F2 | - | |
| David E. Lazar - Director | Grant or award | Series B Preferred Shares | 1,000,000 | - footnote F2 | - | |
| David E. Lazar - Director | Grant or award | Series C Preferred Shares | 1,000,000 | - footnote F2 | - | |
| ||||||
| Grant or award | Ordinary Shares | 290,000 | $0.00 footnote F1 | - | ||
| ||||||
| Heinrich Dreismann - Director | Grant or award | Ordinary Shares | 45,000 | $0.00 footnote F1 | - | |
| ||||||
| Grant or award | Ordinary Shares | 45,000 | $0.00 footnote F1 | - | ||
| ||||||
| Guido Baechler - Officer | Grant or award | Ordinary Shares | 440,000 | $0.00 footnote F1 | - | |
| ||||||
| Kevin Michael Donahue - 10% Owner | Open-market purchase | Common Stock | 685,000 | $1.51 | $1.03M | |
| Kevin Michael Donahue - 10% Owner | Open-market purchase | Common Stock | 643,850 | $402,000.00 | - | |
Recent QUCY Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
QUCY insider trading FAQ
What is the latest insider trade for QUCY?
Quantum Cyber N.V. (QUCY) had 11 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for QUCY runs to 22 Form 4 filings, the earliest from 2026-01-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QUCY stock?
No insider purchases of QUCY were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling QUCY stock?
No insider sales of QUCY were filed in the last 90 days.
Where can I see QUCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QUCY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William J. Caragol view on EDGAR
- - David E. Lazar view on EDGAR
- - Peter O'Rourke view on EDGAR
- - David Natan view on EDGAR
- - William J. Caragol view on EDGAR
- - Louis R. Buffalino view on EDGAR
- - Avraham Ben-Tzvi view on EDGAR
- - Peter O'Rourke view on EDGAR
- - David Natan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where QUCY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QUCY with a 7-day demo
- QUCY on your watchlist
- Every QUCY Form 4 filing on record
- Up to 3 months of QUCY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive